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A B S T R A C T
Drug seizures involving a wide variety of emerging new psychoactive substances (NPS) call for new
approaches for instant quantiﬁcation and valuation. Liquid chromatography–chemiluminescence
nitrogen detection (LC–CLND) was used in the quantiﬁcation of opioids with a single secondary
standard (caffeine), utilizing the detector's equimolar response to nitrogen. The mean N-equimolarity of
CLND for ten fentanyl derivatives and U-47700 by the present LC–CLND method was 96.4% (range 91–
101%). The furanylfentanyl samples consisted of 112 powdery samples with a mean (median, range)
hydrochloride purity of 13% (4.9%, 0.08–100%). The purity distribution of the furanylfentanyl samples was
distinctly bipartite, showing only lower than 9% (N = 98) and higher than 60% (N = 14) purities. The
carfentanil samples consisted of eight brownish sticky samples with a mean (median, range)
hydrochloride purity of 0.064% (0.063%, 0.052–0.092%). The U-47700 samples consisted of seven
powdery samples with a mean (median, range) hydrochloride purity of 89.0% (100%, 51–100%). The
present application to synthetic opioid analysis widens the scope of the established LC-CLND method,
previously found useful for single-calibrant quantiﬁcation of stimulant/hallucinogenic and cannabinoid
type of NPS.
© 2019 Elsevier B.V. All rights reserved.
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Opioids are essential in the medical treatment of severe pain
but they are also largely abused by drug addicts. During the recent
years, the illicit drugs scene has been shaken by the emergence of
various fentanyl derivatives and other potent opioids onto the
stage of new psychoactive substances (NPS) [1,2]. As the fentanyl
structure is exceptionally prone to be modiﬁed, the number of
different derivatives with pharmacological activity is high. It has
been estimated that out of approximately 1400 fentanyl
analogues, more than 200 compounds have been described in
the literature [3].
The diversity and rapid turnover of NPS makes their analysis
challenging, as high-quality reference standards are not readily
accessible.Whileunequivocal identiﬁcation of seizedsamplescan be
carried out by a combination of high resolution mass spectrometry
and NMR spectroscopy, the purity estimation in the absence of* Corresponding author at: National Institute for Health and Welfare, Forensic
Toxicology Unit, PO Box 30, FI-00271 Helsinki, Finland.
E-mail address: ilkka.ojanpera@helsinki.ﬁ (I. Ojanperä).
http://dx.doi.org/10.1016/j.forsciint.2019.110001
0379-0738/© 2019 Elsevier B.V. All rights reserved.reference standards requires a technique with universal or predict-
able responseasopposedto mass spectrometry. Inourearlier papers,
we have studied liquid chromatography–chemiluminescence
nitrogen detection (LC–CLND) in the quantiﬁcation of NPS with a
single secondary standard (caffeine), utilizing the detector's
equimolar response to nitrogen [4,5]. The developed method
enabled analysis of phenethylamines, cathinones and tryptamines,
as well as to nitrogen containing synthetic cannabinoids, at a level of
uncertainty of measurement (<20%) comparable to conventional
quantiﬁcation methods [5].
Here, using essentially the same conditions for sample
preparation and LC-CLND analysis as in the previous paper [5],
we focus on the quantiﬁcation of fentanyl derivatives and report
purity values for seized samples of furanylfentanyl, carfentanil and
U-47700.
2. Materials and methods
2.1. Materials
Seized material with previously positively identiﬁed main
components was obtained through the National Bureau of
2 I. Rasanen et al. / Forensic Science International 305 (2019) 110001Investigation and from the Finnish Customs Laboratory for
quantitative analysis by LC–CLND.
The secondary reference standard used for quantiﬁcation by
LC–CLND was caffeine (Sigma–Aldrich C1778, purity 98.9%).
Certiﬁed reference standards were used to determine the
equimolarity of the CLND detector. Standards were selected
according to their availability to the laboratory. Fentanyl solution
(99.9%) 1.0 mg/mL in methanol was from LGC GmbH (Luckenwalde,
Germany), para-ﬂuorofentanyl HCl (>95%) and furanylfentanyl HCl
(98.9%) were from Cayman Chemical (Ann Arbor, MI, USA),
U-47700 HCl (92.8  0.5%) was from Chiron (Trondheim, Norway),
alpha-methylfentanyl HCl (98%) was from Toronto Research
Chemical Inc (North York, ON, Canada), cis-3-methylfentanyl HCl
(99.6%), trans-3-methylfentanyl HCl (98.7%) and norfentanyl HCl
hydrate (99.9%) were from Lipomed (Arlesheim, Switzerland),
carfentanil citrate was from United Nations Narcotics Lab (Vienna,
Austria), remifentanil HCl (99.5%) was from GlaxoSmithKline
(Durham, UK) and sufentanil citrate (99.6%) was from Janssen
Pharmaceutica N.V. (Beerse, Belgium).
2.2. Apparatus
LC–CLND analysis was performed with an Agilent Technologies
(Santa Clara, CA, USA) 1100 series liquid chromatograph equipped
with an autosampler, binary pump, column oven, 1260 Inﬁnity
degasser, and 1260 Inﬁnity UV diode array detector (DAD).
Chromatographic separation was performed with a Phenomenex
(Torrance, CA, USA) Luna PFP(2) 100  2 mm (3 mm) column and a
4  2 mm PFP precolumn. The nitrogen-speciﬁc detector was an
Antek (PAC, Houston, TX, USA) 8060 CLND, coupled online after the
DAD. The detector was interfaced with the computer using an
Agilent 35900E analog-to-digital converter.
2.3. Sample preparation
General procedure: a quantity of 10–20 mg of the seized
material was dissolved in 0.1% formic acid (FA): methanol (MeOH)
9:1 v/v to obtain a solution of 10 mg/mL of seized material. This
solution was analyzed directly in case of low-content samples or
diluted proportionally to obtain a solution of 1.0 mg/mL of seized
material for LC–CLND analysis.
For some high-content samples, a solution of 1.0 mg/mL was
prepared in MeOH and diluted with 0.1% FA to obtain a solution of
0.10 mg/mL of seized material. In all cases, sample preparation was
carried out to obtain an analyte concentration corresponding to
approximately 20–80 ng of nitrogen per injection.
2.4. LC-CLND analysis
LC separation was performed in gradient mode at 40 C. The
mobile phase components were 0.1% FA and methanol. Flow rateTable 1
Equimolarity of nitrogen detection for fentanyl derivatives and U-47700 by LC–CLND.
Compound Retention time (min) Mean equim
Norfentanyl 8.86 96 
Remifentanil 10.95 95 
U-47700 12.35 97 
Fentanyl 12.51 96 
Furanylfentanyl 12.74 98 
α-Methylfentanyl 12.79 98 
para-Fluorofentanyl 12.89 101 
trans-3-Methylfentanyl 13.04 91 
cis-3-Methylfentanyl 13.07 93 
Carfentanil 13.11 98 
Sufentanil 13.50 97 
a Three concentration levels within the ng/N range indicated were analysed in dupliwas 0.25 mL/min and injection volume 10 mL. The proportion of
methanol was increased from 10% to 90% over 15 min and held at
90% for 5 min. Post-time was 10 min. The DAD signal was recorded
at 230 nm and peak controlled spectra were recorded at 210–400
nm. Although the compounds were pre-identiﬁed by other
methods, the DAD signal was used to conﬁrm the peak purity
by means of the Agilent ChemStation similarity factor algorithm.
For CLND analysis, the inlet oxygen ﬂow was 250 mL/min,
helium ﬂow 50 mL/min, and make-up helium ﬂow 50 mL/min. The
ozone generator oxygen ﬂow was 25 mL/min, and furnace
temperature 1050 C. The photomultiplier tube voltage was set
at 750 V, and the ampliﬁcation factor was 1. UV and CLND data
were processed using Agilent ChemStation. External calibration
was performed at the beginning of each data acquisition sequence
with caffeine as standard. Caffeine (2–4 mg) was weighed and
dissolved in 0.1% FA: methanol 90:10 (v/v) to obtain a solution of 1
mg/mL. Subsequently, 20 mL of this solution was diluted with 180
mL of 0.1% FA: methanol 90:10 (v/v) to obtain a solution of 0.10 mg/
mL, and this solution was further diluted to 0.01 mg/mL,
respectively. Caffeine calibration standards were prepared from
these standards by diluting with 0.1% FA: methanol 90:10 (v/v) to
obtain caffeine concentrations of 1.0, 2.0, 3.0, 4.0, 5.0, 10, 20, 30, 40
and 50 mg/mL which were equivalent to the calibration points of
2.9, 5.8, 8.7, 11.5, 14.4, 28.9, 57.7, 86.6, 115 and 144 ng of nitrogen
per injection. The caffeine curve ﬁt was found to be linear with
R2 >0.999.
2.5. Equimolarity
The equimolarity of nitrogen detection was investigated by
analyzing different concentration levels (three levels per
compound) of certiﬁed reference standard solutions of selected
compounds using the caffeine calibration. All analyses were
performed in duplicate. Equimolarity was calculated in the
concentration level of approximately 20–80 ng of nitrogen per
injection, depending on the nitrogen content of the compound.
Equimolarity was reported as an average of calculated
equimolarities at the different concentration levels.
3. Results and discussion
Table 1 shows the N-equimolarity of chemiluminescence
nitrogen detection for ten fentanyl derivatives and U-47700 by
the present LC–CLND method. The grand mean (range) equimolarity
of the means of the eleven substances was 96.4% (91–101%). Within
the nitrogen range indicated in the table, the equimolarity showed
no concentration dependence.
Seized samples containing furanylfentanyl, carfentanil and
U-47700 were quantiﬁed by the caffeine-calibrated LC–CLND
method described above. These drugs were identiﬁed by high
resolution mass spectrometry and, initially by NMR spectroscopy,olarity (%) Range ng N/inj. Equimolarity range (%)a
24–104 95.0–96.5
15–71 94.7–95.7
18–84 96.5–99.2
16–79 94.8–98.7
15–70 94.1–99.2
14–72 89.0–104.0
15–77 97.2–103.7
16–90 83.4–95.4
16–73 91.9–99.0
15–70 93.1–100.5
13–65 95.4–98.4
cate.
Table 2
Purity distribution of 112 seized furanylfentanyl samples.
Purity as HCl% N
0–0.99 1
1.0–1.9 1
2.0–2.9 32
3.0–3.9 17
4.0–4.9 7
5.0–5.9 25
6.0–6.9 10
7.0–7.9 4
8.0–8.9 1
9.0–59 0
60–69 5
70–79 6
80–89 1
90–100 2
I. Rasanen et al. / Forensic Science International 305 (2019) 110001 3without other illicit drug ﬁndings prior to submitting the samples
for quantiﬁcation by LC–CLND. However, the DAD signal was used
to assess the peak purity for CLND calculations, applying a DAD
peak purity criterion of 99% as well as visual inspection. The
expanded uncertainty of measurement, calculated as shown before
[5], was always <20% as the systematic error component was low.
The furanylfentanyl samples, seized between December 2016
and November 2018 by the customs or police, consisted of 112
powdery samples with a mean (median, range) hydrochloride
purity of 13% (4.9%, 0.08–100%). Table 2 describes the purity
distribution of the furanylfentanyl samples showing a distinctly
bipartite nature of low (lower than 9%) and high (higher than 60%)
purity samples. The majority of the samples were of low purity, and
they originated from small 1–10 g batches that obviously were
intended for personal use on the Finnish market with limited
demand for the product.
The carfentanil samples, seized in August and December 2017
by the police, consisted of eight brownish sticky samples with a
mean (median, range) hydrochloride purity of 0.064% (0.063%,
0.052–0.092%).
The U-47700 samples, seized between December 2016 and
August 2017 by the police and customs, consisted of seven
powdery samples with a mean (median, range) hydrochloride
purity of 89.0% (100%, 51–100%).
The limitations of the LC-CLND method include only moderate
chromatographic resolution and the requirement of a nitrogen
atom in the analyte molecule. It is acknowledged that any DAD
peak purity algorithm can only conﬁrm the presence of impurities
and never prove absolutely that the peak is pure. The CLND
response is sensitive to the actual nitrogen conﬁguration for
compounds containing adjacent nitrogen atoms [6]. However,
these limitations did not negatively affect the presented analysis,
because all the studied drugs were nitrogenous and there were no
interfering signals in the relevant chromatographic region. The
common adulterants caffeine and paracetamol, for instance, eluted
much earlier than the opioids investigated. Clearly, the method is
amenable to even more general quantiﬁcation of synthetic opioids.
As stated in the European Drug Report 2019 by the European
Monitoring Centre for Drugs and Drug Addiction (EMCDDA), new
synthetic opioids pose a serious threat to individual and public
health, while fentanyl derivatives make up the majority of the 49
new opioids monitored by the EMCDDA [7]. The present analytical
approach meets the requirements posed by the rapidly changing
illicit drug scene for instant quantiﬁcation and valuation of
drug seizures. Our future studies will focus on the development of
parallel drug analysis by CLND and high resolution mass
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